Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates.

benzinga_article

Jul 16, 2026 at 01:08 PM

Arbutus Biopharma shares are trading higher after the company announced the filing of three international lawsuits seeking to enforce patent protecting LNP technology against Pfizer, BioNTech and certain or other affiliates.

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

Jan 7, 2026 at 08:30 AMWill GLP-1 spillover and AI empowerment make biomedicine the "alternative" for tech stocks in 2026?
Dec 31, 2025 at 01:30 PMUnfazed by Trump's pressure, 350 prescription drugs in the U.S. will see price increases next year
Dec 16, 2025 at 01:59 PMGlobal news you need to know before the U.S. stock market opens on Tuesday
Nov 6, 2025 at 08:07 AMThe merger and acquisition battle intensifies: Pfizer and Novo Nordisk's billion-dollar bid for the "new heavyweight" in…

Related Stocks

BioNTech SE

USBNTX

+0.34%

Arbutus Pharma

USABUS

0.00%

Pfizer

USPFE

+0.25%

LongbridgeAI